Re–Vana Therapeutics is an ocular pharmaceuticals and drug delivery company focused on the development and commercialisation of innovative long–acting biodegradable drug delivery platforms to treat chronic eye diseases.
GLT’s primary function is to carry out innovative, industry–led research and development to provide green and sustainable solutions to industrial problems.